Torys recognized as a Canadian leader in 2016 edition of The Legal 500: Canada

Torys has been recommended in 13 practice areas, and recommended as a top-tier firm in four practice areas.

Tax Horizons 2015

Our seasoned Power lawyers have extensive expertise advising on virtually every commercial power technology.

We are widely recognized as having one of the premier life sciences practices in both the U.S. and Canada, providing innovative advice to our biotech, pharmaceutical, medical device and other health technology clients.

For Safe Harbor, Steer North

Many questions follow in the wake of the European Court of Justice ruling invalidating the EU-U.S. Safe Harbor regime for the transfer of personal information. This decision is expected to have significant long-term effects for companies engaged in multijurisdictional business, data processing, and litigation.

Companies will need to adapt in the long term to a new approach, but interim measures to ensure business continuity exist, and may create opportunity for businesses with Canadian operations.

Ontario Cap-and-Trade Program Design Options Released

The Ontario Ministry of the Environment and Climate Change has released a discussion paper titled Cap-and-Trade Program Design Options, providing the public with its first detailed look at the design options being considered for the province’s anticipated greenhouse gas emissions cap-and-trade system.

Read our analysis of the proposed system’s potential impact.

Torys is Proud to Support Give a Day

For the tenth year in a row, Torys is proud to support and participate in the Give a Day to World AIDS campaign.

Our Work
food and drug law insights
Infrastructure Practice

Laurie Duke and Janan Paskaran Recognized as 2015 Lexpert® Rising Stars

Laurie Duke and Janan Paskaran have been selected as Lexpert’s Rising Stars: Leading Lawyers Under 40.

120-Day Poison Pill May Force Regulators' Hand Ahead of New "Just Say Slow" Bid Regime

Read about the Canadian Oil Sands’ 120-day poison pill in the context of Canada’s bid regime change.